Save up -80% on Tipranavir

Note: this is a drug discount program, not an insurance plan.
RX BIN: 015558RX PCN: HTGroup ID: DDN6600Card Holder ID: DDN6600
Pharmacists and Patients support.

2019 Price of Aptivus

$1,677.30120 capsules/250mg
Price with discount in nearest pharmacy. Price may vary.

Claim your free Tipranavir discount card

We offer free Tipranavir coupons and discounts that may help you save up to 80% off the retail price in your local pharmacy. Just print your coupon! It’s ready to use and never expire. Present your manufacturer copay card in most local pharmacies to get a discount on Tipranavir every time. What are you waiting for? Claim your prescription drug card now!

Walgreens pharmacy
Walgreens pharmacy
CVS pharmacy
CVS pharmacy
Walmart pharmacy
Walmart pharmacy
Ride AID pharmacy
Ride AID pharmacy
CVS Target pharmacy
CVS Target pharmacy
Kroger pharmacy
Kroger pharmacy
rx

Get your Prescription

safe

It’s safe and free

pharmacy

Buy drugs in pharmacy

save money

Save money each time

Tipranavir volume of distribution

It has a volume of distribution of 8-10 L when boosted with 200mg of ritonavir. Tipranavir reaches an average Cmax of 77.6 ± 16.6 µM (males) and 94.8 ± 22.8 µM (females) ~ 3 hours after dosing.

RX Prescription
Ask Your therapeut before taking any drugs.

About RX24Drugs

2018 Statistics

discount card

Discount Cards 16,000+

benefit

Clients Benefit 29%

savings

Total savings $4,735,080

What is Tipranavir

Tipranavir is a sulfonamide-containing dyhydropyrone and a nonpeptidic protease inhibitor that targets the HIV protease. It is administered with ritonavir in combination therapy to treat HIV infections.

Tipranavir mechanism of action

Tipranavir (TPV) is a non-peptidic HIV-1 protease inhibitor that inhibits the processing of the viral Gag and Gag-Pol polyproteins in HIV-1 infected cells, thus preventing formation of mature virions. Two mechanisms are suggested in regards to the potency of tipranavir: 1. Tipravanir may bind to the active site of the protease enzyme with fewer hydrogen bonds than peptidic protease inhibitors, which results in increased flexibility, allowing it to fit into the active site of the enzyme in viruses that have become resistance to other protease inhibitors. This also enables tipranavir to adjust to amino acid substitutions at the active site. 2. Tipranavir’s strong hydrogen bonding interaction with the amide backbone of the protease active site Asp30 may lead to its activity against resistant viruses.

Dosage forms of Tipranavir

FormRouteStrength
Capsuleoral250 mg
Capsule, liquid filledoral250 mg/1
Solutionoral100 mg/mL

Prescription Generics

false

International Brands

Aptivus

Synonyms

Manufacturers

Boehringer Ingelheim (Canada) Ltd Ltee

CAS number

174484-41-4

UNII

ZZT404XD09

State

solid

Affected organisms

Human Immunodeficiency Virus

Indication of Tipranavir

For combination antiretroviral treatment of HIV-1 infected adult patients with evidence of viral replication, who are highly treatment-experienced or have HIV-1 strains resistant to multiple protease inhibitors.

Toxicity of Tipranavir

Oral LD sub 50 /sub in rat is over 5,000 mg/kg. Side effects include thirst and hunger, unexplained weight loss, increased urination, fatigue, and dry, itchy skin.

RX24 Drugs Disclaimer: consult your healthcare provider before buying a Tipranavir on prescription or using an RX manufacturer savings coupon. Content on this page is provided for informational purposes only. Any use of this information is at your own risk.

Get lower price on Tipranavir now!